MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with N

Nabilone

Nabilone 1mg capsules

Compatible

Stability notes for Nabilone 1mg capsules

No stability data in MCAs available but no theoretical concerns with product.

Provenance

This recommendation is based on the products nabilone 1mg capsules (Brown & Burk UK Ltd).

Suppliers

Nabilone 1mg capsules (Alliance Healthcare (Distribution) Ltd)
Nabilone 1mg capsules (Brown & Burk UK Ltd)
Nabilone 1mg capsules (Special Order)

Nabilone 250microgram capsules

Compatible

Stability notes for Nabilone 250microgram capsules

No stability data in MCAs available but no theoretical concerns with product.

Provenance

This recommendation is based on the products nabilone 0.25mg and 1mg capsules (Brown & Burk UK Ltd).

Supplier

Nabilone 250microgram capsules (Brown & Burk UK Ltd)

Nabilone 500microgram capsules

No stability information

Stability notes for Nabilone 500microgram capsules

There are no stability notes for this medicine.

Supplier

Nabilone 500microgram capsules (Special Order)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.